Discovery of 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-(tert-butyl)pyridine-3-sulfonamide (CZC24758), as a potent, orally bioavailable and selective inhibitor of PI3K for the treatment of inflammatory disease

被引：23
|
作者：
Sunose, Mihiro [1 ]
Bell, Kathryn [1 ]
Ellard, Katie [1 ]
Bergamini, Giovanna [2 ]
Neubauer, Gitte [2 ]
Werner, Thilo [2 ]
Ramsden, Nigel [1 ]
机构：
[1] Cellzome Ltd, Saffron Walden CB10 1XL, England
[2] Cellzome AG, D-69117 Heidelberg, Germany
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2012年 / 22卷 / 14期
关键词：
PI3K gamma; Inflammation; Triazolopyridine; Collagen induced arthritis; Rheumatoid arthritis; PHOSPHOINOSITIDE 3-KINASE PATHWAY; RHEUMATOID-ARTHRITIS; PI3K-GAMMA; CANCER; ACTIVATION; ISOFORM; KINASE; GAMMA;
D O I：
10.1016/j.bmcl.2012.05.090
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Herein, we disclose the discovery of a series of 7-substituted triazolopyridines which culminated in the identification of 14 (CZC24758), a potent, orally bioavailable small-molecule inhibitor of PI3K gamma, an attractive drug target for inflammatory and autoimmune disorders. Compound 14 has excellent selectivity across the kinome, demonstrates good potency in cell based assays and furthermore exhibits in vivo efficacy in a collagen induced arthritis model in mouse after oral dosing. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码：4613 / 4618
页数：6
相关论文
共 50 条
  • [31] Pharmacological characterization of a novel potent, selective, and orally active phosphodiesterase 10A inhibitor, PDM-042 [(E)-4-(2-(2-(5,8-dimethyl-[1,2,4] triazolo [1,5-a] pyrazin-2-yl) vinyl)-6-(pyrrolidin-1-yl) pyrimidin-4-yl) morpholine] in rats: potential for the treatment of schizophrenia
    Arakawa, Keita
    Maehara, Shunsuke
    Yuge, Natsuko
    Ishikawa, Makoto
    Miyazaki, Yutaka
    Naba, Hiroyasu
    Kato, Yutaka
    Nakao, Kazunari
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2016, 4 (04):
  • [32] Discovery of (S)-2-(1-(4-Amino-3-(3-fluoro-4-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)propyl)-3-cyclopropyl-5-fluoroquinazolin-4(3H)-one (IHMT-PI3Kδ-372) as a Potent and Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease
    Li, Feng
    Liang, Xiaofei
    Jiang, Zongru
    Wang, Aoli
    Wang, Junjie
    Chen, Cheng
    Wang, Wenliang
    Zou, Fengming
    Qi, Ziping
    Liu, Qingwang
    Hu, Zhenquan
    Cao, Jiangyan
    Wu, Hong
    Wang, Beilei
    Wang, Li
    Liu, Jing
    Liu, Qingsong
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (22) : 13973 - 13993
  • [33] Discovery of (R)-6-Cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one (PF-00868554) as a Potent and Orally Available Hepatitis C Virus Polymerase Inhibitor
    Li, Hui
    Tatlock, John
    Linton, Angelica
    Gonzalez, Javier
    Jewell, Tanya
    Patel, Leena
    Ludlum, Sarah
    Drowns, Matthew
    Rahavendran, Sadayappan V.
    Skor, Heather
    Hunter, Robert
    Shi, Stephanie T.
    Herlihy, Koleen J.
    Parge, Hans
    Hickey, Michael
    Yu, Xiu
    Chau, Fannie
    Nonomiya, Jim
    Lewis, Cristina
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (05) : 1255 - 1258
  • [34] Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis
    Ruminski, Peter G.
    Massa, Mark
    Strohbach, Joseph
    Hanau, Cathleen E.
    Schmidt, Michelle
    Scholten, Jeffrey A.
    Fletcher, Theresa R.
    Hamper, Bruce C.
    Carroll, Jeffery N.
    Shieh, Huey S.
    Caspers, Nicole
    Collins, Brandon
    Grapperhaus, Margaret
    Palmquist, Katherine E.
    Collins, Joe
    Baldus, John E.
    Hitchcock, Jeffrey
    Kleine, H. Peter
    Rogers, Michael D.
    McDonald, Joseph
    Munie, Grace E.
    Messing, Dean M.
    Portolan, Silvia
    Whiteley, Laurence O.
    Sunyer, Teresa
    Schnute, Mark E.
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (01) : 313 - 327
  • [35] Discovery of N-(3-(5-((3-acrylamido-4-(morpholine-4-carbonyl) phenyl)amino)-1-methyl-6-oxo-1,6-dihydropyridin-3-yl)-2-methylphenyl)-4-(tert-butyl)benzamide (CHMFL-BTK-01) as a highly selective irreversible Bruton's tyrosine kinase (BTK) inhibitor
    Liang, Qianmao
    Chen, Yongfei
    Yu, Kailin
    Chen, Cheng
    Zhang, Shouxiang
    Wang, Aoli
    Wang, Wei
    Wu, Hong
    Liu, Xiaochuan
    Wang, Beilei
    Wang, Li
    Hu, Zhenquan
    Wang, Wenchao
    Ren, Tao
    Zhang, Shanchun
    Liu, Qingsong
    Yun, Cai-Hong
    Liu, Jing
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 131 : 107 - 125
  • [36] Discovery of 2-(cyclopropanecarboxamido)-N-(5-((1-(4-fluorobenzyl) piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide as a potent dual AChE/GSK3β inhibitor for the treatment of Alzheimer's disease: Significantly increasing the level of acetylcholine in the brain without affecting that in intestine
    Jiang, Xueyang
    Liu, Chang
    Zou, Manxing
    Xie, Huanfang
    Lin, Tailiang
    Lyu, Weiping
    Xu, Jian
    Li, Yuan
    Feng, Feng
    Sun, Haopeng
    Liu, Wenyuan
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 223
  • [37] Discovery of 1-[3-aminobenzisoxazol-5′-yl]-3-trifluoromethyl-6-[2′-(3-(R)-hydroxy-N-pyrrolidinyl)methyl-[1,1′]-biphen-4-yl]-1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-one (BMS-740808), a potent, efficacious and orally bioavailable inhibitor of blood coagulation factor Xa
    Orwat, MJ
    Fevig, JM
    Quan, ML
    Galemmo, RA
    Amparo, E
    Alexander, RS
    Rossi, KA
    Smallwood, AM
    Wong, PC
    Luettgen, JM
    Knabb, RM
    Bai, SA
    He, K
    Wexler, RR
    Lam, PYS
    Pinto, DJP
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2663 - U2663
  • [38] Discovery of a potent, orally bioavailable and highly selective human neuronal nitric oxide synthase (nNOS) inhibitor, N-(1-(piperidin-4-yl)indolin-5-yl) thiophene-2-carboximidamide as a pre-clinical development candidate for the treatment of migraine
    Annedi, Subhash C.
    Maddaford, Shawn P.
    Ramnauth, Jailall
    Renton, Paul
    Rybak, Taras
    Silverman, Sarah
    Rakhit, Suman
    Mladenova, Gabriela
    Dove, Peter
    Andrews, John S.
    Zhang, Dongqin
    Porreca, Frank
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 : 94 - 107
  • [39] Discovery of N-(4-(3-(2-Aminopyrimidin-4-yl)pyridin-2-yloxy)phenyl)-4-(4-methylthiophen-2-yl)phthalazin-1-amine (AMG 900), A Highly Selective, Orally Bioavailable Inhibitor of Aurora Kinases with Activity against Multidrug-Resistant Cancer Cell Lines
    Geuns-Meyer, Stephanie
    Cee, Victor J.
    Deak, Holly L.
    Du, Bingfan
    Hodous, Brian L.
    Hanh Nho Nguyen
    Olivieri, Philip R.
    Schenkel, Laurie B.
    Vaida, Karina R.
    Andrews, Paul
    Bak, Annette
    Be, Xuhai
    Beltran, Pedro J.
    Bush, Tammy L.
    Chaves, Mary K.
    Chung, Grace
    Dai, Yang
    Eden, Patrick
    Hanested, Kelly
    Huang, Liyue
    Lin, Min-Hwa Jasmin
    Tang, Jin
    Ziegler, Beth
    Radinsky, Robert
    Kendall, Richard
    Patel, Vinod F.
    Payton, Marc
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (13) : 5189 - 5207
  • [40] Discovery of N-[4-[6-tert-Butyl-5-methoxy-8-(6-methoxy-2-oxo-1H-pyridin-3-yl)-3-quinolyl]phenyl]methanesulfonamide (RG7109), a Potent Inhibitor of the Hepatitis C Virus NS5B Polymerase
    Talamas, Francisco X.
    Abbot, Sarah C.
    Anand, Shalini
    Brameld, Ken A.
    Carter, David S.
    Chen, Jun
    Davis, Dana
    de Vicente, Javier
    Fung, Amy D.
    Gong, Leyi
    Harris, Seth F.
    Inbar, Petra
    Labadie, Sharada S.
    Lee, Eun K.
    Lemoine, Remy
    Le Pogam, Sophie
    Leveque, Vincent
    Li, Jim
    McIntosh, Joel
    Najera, Isabel
    Park, Jaehyeon
    Railkar, Aruna
    Rajyaguru, Sonal
    Sangi, Michael
    Schoenfeld, Ryan C.
    Staben, Leanna R.
    Tan, Yunchou
    Taygerly, Joshua P.
    Villasenor, Armando G.
    Weller, Paul E.
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (05) : 1914 - 1931
12345